Company: CDLX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001666071-25-000159
Chunk: 102

Company: Cardlytics, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 1
Chunk 102
---
987)$69,697 

Three Months Ended September 30, 2024:

  AdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotal Common Stock SharesAmountBalance – June 30, 202449,402 $9 $1,346,876 $2,953 $(1,139,805)$210,033 Stock-based compensation— — 9,297 — — 9,297 Settlement of restricted stock940 — — — — — Other comprehensive loss— — — (4,451)— (4,451)Net Loss— — — — (145,182)(145,182)Balance – September 30, 202450,342 $9 $1,356,173 $(1,498)$(1,284,987)$69,697 

See notes to the condensed consolidated financial statements7

CARDLYTICS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Amounts in thousands)

 Nine Months EndedSeptember 30, 20252024Operating activitiesNet Loss$(95,238)$(173,715)Adjustments to reconcile net loss to net cash used in operating activities:Credit loss expense1,782 3,980 Depreciation and amortization19,039 19,749 Amortization of financing costs charged to interest expense1,194 1,235 Amortization of right-of-use assets1,789 1,627 Gain on disposal or divestiture(4,831)— Gain on debt extinguishment— (13,017)Stock-based compensation expense22,617 31,694 Impairment of goodwill and intangible assets58,843 131,595 Change in contingent consideration102 110 Other non-cash income, net(6,251)(4,136)Change in operating assets and liabilities:Accounts receivable14,808 12,909 Prepaid expenses and other assets(230)(229)Accounts payable(193)820 Other accrued expenses1,762 (3,192)Partner Share liability(10,920)(18,330)Consumer Incentive liability(7,993)(2,903)Net cash used in operating activities(3,720)(11,803)Investing activitiesAcquisition of